● Single award · contract
Initiate the Management, Oversight, and Conduct of the Niaid Dmid Clinical Trial Titled "a Multicenter…
A single federal award, with both ends of the trail linked.
$72.4M
total award value
2020
action date
44 mo
period
75N91020F00010
PIID
Description
Initiate the Management, Oversight, and Conduct of the Niaid Dmid Clinical Trial Titled "a Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19".
Awarding agencyDepartment of Health and Human Services →
RecipientLeidos Biomedical Research Inc →
Place of performanceMaryland →
CategoryNAICS 541715PSC AN12
Competed?Not recorded✓ from source
Total (exact)$72,440,795
More awards to Leidos Biomedical Research Inc
awarded 2008$4.8B
awarded 2020$1.8B
awarded 2019$432.4M
awarded 2024$398.9M
awarded 2025$327.1M
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.